Crescent Grove Advisors’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-26,937
Closed -$675K 278
2024
Q4
$675K Hold
26,937
0.07% 140
2024
Q3
$676K Hold
26,937
0.07% 144
2024
Q2
$670K Sell
26,937
-302
-1% -$7.48K 0.07% 138
2024
Q1
$676K Hold
27,239
0.07% 148
2023
Q4
$674K Buy
+27,239
New +$667K 0.08% 141

Other funds holding IBDQ

Crescent Grove Advisors's IBDQ Position: Q1 2025 in Review

Crescent Grove Advisors sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q1 2025, closing a stake of 26,937 shares — an estimated $675K sold.

Crescent Grove Advisors first reported a position in IBDQ in Q4 2023 and held it in 5 quarters. The position peaked at $676K in Q3 2024. 397 funds tracked by Wall St. Rank hold IBDQ as of Q1 2025.

  • Crescent Grove Advisors reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q1 2025 after selling out during the quarter.
  • Crescent Grove Advisors sold 26,937 iShares iBonds Dec 2025 Term Corporate ETF shares in Q1 2025, an estimated $675K.
  • Crescent Grove Advisors first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2023 and held it in 5 quarters.
  • Crescent Grove Advisors's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $676K in Q3 2024.
  • 397 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q1 2025.

Based on Crescent Grove Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.